HER2-positive apocrine carcinoma of the breast: a population-based analysis of treatment and outcome.

Faruk SkenderiMohamad Alhoda Mohamad AlahmadEmin TahirovicYaman M AlahmadZoran GatalicaSemir Vranic

Published in: Breast cancer research and treatment (2022)

Our study confirms the rarity of the APO and reveals that SR status in APO does not affect these patients' prognosis. HER2+/APO tumors tend to have a less aggressive phenotype and a more favorable outcome despite a markedly lower ER/PR positivity.

Keyphrases

end stage renal disease
ejection fraction
chronic kidney disease
prognostic factors
peritoneal dialysis
combination therapy
endoplasmic reticulum